← Browse by Condition
Medical Condition
haematological malignancy
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 2, Phase 3
NCT05770544 Phase 2, Phase 3
Recruiting
DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young Adult Patients With ROS1 Gene Fusion-Positive Cancers.
Enrollment
30 pts
Location
United Kingdom
Sponsor
Cancer Research UK
NCT06988475 Phase 2, Phase 3
Recruiting
DETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET Dysregulations
Enrollment
30 pts
Location
United Kingdom
Sponsor
Cancer Research UK
NCT05768178 Phase 2, Phase 3
Recruiting
DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers.
Enrollment
30 pts
Location
United Kingdom
Sponsor
Cancer Research UK